Latest News from PSNC

Visit PSNC website
  • The recently appointed Chief Pharmaceutical Officer (CPhO) for England, David Webb, delivered a keynote speech in person at the National Meeting of LPCs and PSNC on Thursday 17th May 2022. As the new head of the pharmacy professions, he set out his personal priorities for the next few years. At the start of his speech,...
  • Pharmacists and pharmacy technicians are reminded that they must complete the Discharge Medicines Service (DMS) Declaration of Competence (DoC) before providing DMS, which became an Essential service earlier this year. Even if pharmacies are not yet receiving referrals from hospitals, community pharmacy contractors should be ready to provide the service, which includes ensuring staff have...
  • Update 25/05/22: Additional batches added to recall:  Batch Number Expiry Date Pack Size First Distributed 920503 05/2022 25 x 100ml 29/11/2019 920506 05/2022 25 x 100ml 17/12/2019 920508 05/2022 25 x 100ml 07/01/2020 930503 07/2022 25 x 100ml 21/01/2020 930504 07/2022 25 x 100ml 07/02/2020 930505 07/2022 25 x 100ml 25/02/2020 931501 07/2022 25 x...
  • Manage Your Service (MYS) users will have received an email from the NHS Business Services Authority (NHSBSA) informing them of an issue relating to the totals of Community Pharmacist Consultation Service (CPCS) claims displayed in the Manage Your Service (MYS) portal.  If contractors have recently amended a record on their point of care system for...
  • Following the announcement that a further ten new Serious Shortage Protocols (SSPs) were issued on 20 May 2022, the NHS Business Services Authority (NHSBSA) have now published the endorsement guidance for the new SSPs on the NHSBSA’s website. Due to the number of different HRT SSPs available for affected HRT medicine, pharmacists must ensure that they...
  • Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Lenzetto®) 1.53mg/dose transdermal spray. MSN/2022/049 Tier 2 – medium impact Date of issue 23rd May 2022 Estradiol (Lenzetto®) 1.53mg/dose transdermal spray is in limited supply until mid-July 2022. Three Serious Shortage Protocols (SSP) were issued on 20/05/2022 to allow community...